| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $188.6M | -0.2% | +11.2% |
| Cost of Revenue | $33.5M | +1.0% | +13.5% |
| R&D Expense | $44.8M | -5.0% | +14.1% |
| SG&A Expense | $27.0M | -8.7% | +17.2% |
| Operating Income | $21.1M | +55.8% | -18.0% |
| Interest Expense | $467K | +5.4% | +32.3% |
| Pre-tax Income | $20.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $200.7M | -5.2% | -35.6% |
| Short-term Investments | $17.8M | +256.0% | -64.9% |
| Accounts Receivable | $217.6M | +15.2% | +12.6% |
| Current Assets | $476.9M | +3.1% | -17.7% |
| Total Assets | $1.30B | -0.1% | -1.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $138.5M | — | — |
| Capital Expenditures | $28.0M | — | — |
| Investing Cash Flow | -$93.8M | — | — |
| Financing Cash Flow | -$140.8M | — | — |
| Free Cash Flow | $110.5M | — | — |
| +35.0% |
| -30.6% |
| Income Tax | $10.3M | +60.2% | -9.3% |
| Net Income | $10.2M | +16.5% | -43.9% |
| EPS (Basic) | $0.06 | +20.0% | -45.5% |
| EPS (Diluted) | $0.06 | +20.0% | -40.0% |
| $119.9M |
| +14.3% |
| +35.9% |
| Total Liabilities | $219.6M | +6.2% | +20.8% |
| Stockholders' Equity | $1.08B | -1.3% | -4.8% |